Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Nov 14, 2022 | Renibus Therapeutics | Debt Financing | — | Health Care | Yes |
May 12, 2021 | Kala Pharmaceuticals | Post-IPO Debt | — | Biotechnology | Yes |
Jan 11, 2021 | Immunocore | Debt Financing | — | Biotechnology | Yes |
Feb 6, 2020 | Genapsys | Debt Financing | — | Bioinformatics | Yes |
Nov 30, 2018 | Karius | Debt Financing | — | Biotechnology | Yes |
Nov 29, 2017 | VitalConnect | Debt Financing | — | Biotechnology | Yes |
Jan 4, 2017 | Eiger BioPharmaceuticals | Post-IPO Debt | — | Biotechnology | Yes |
May 13, 2016 | ADMA Biologics | Post-IPO Debt | — | Biotechnology | Yes |
Apr 21, 2016 | Nuvectra | Debt Financing | — | Biotechnology | — |
Aug 3, 2015 | Ocera Therapeutics | Post-IPO Debt | — | Biopharma | — |
Jun 22, 2015 | ADMA Biologics | Post-IPO Debt | — | Biotechnology | Yes |
May 5, 2015 | Labcyte | Debt Financing | — | Alternative Medicine | — |
Aug 29, 2014 | HTG Molecular Diagnostics | Debt Financing | — | Biotechnology | — |
Feb 22, 2012 | Horizon Pharma | Post-IPO Debt | — | Biopharma | — |